在 CROI 2022 會議上,約翰霍普金斯大學的 Susan Eshleman 教授( HPTN 083 研究團隊成員之一)對 cabotegravir 抗藥性突變的相關病例進行了分析。 Click here for the full articleTranslated from the original English news article Injected PrEP: breakthrough cases could have been detected sooner (2022) by iKnowledge Up vote 0 Down vote 0